Authors: Zhang, N Wu, BQ Powell, D Wissner, A Floyd, MB Kovacs, ED Toral-Barza, L Kohler, C

Citation: N. Zhang et al., Synthesis and structure-activity relationships of 3-cyano-4-(phenoxyanilino)quinolines as MEK (MAPKK) inhibitors, BIOORG MED, 10(24), 2000, pp. 2825-2828

Authors: Wang, YD Miller, K Boschelli, DH Ye, F Wu, BQ Floyd, MB Powell, DW Wissner, A Weber, JM Boschelli, F

Citation: Yd. Wang et al., Inhibitors of Src tyrosine kinase: The preparation and structure-activity relationship of 4-anilino-3-cyanoquinolines and 4-anilinoquinazolines, BIOORG MED, 10(21), 2000, pp. 2477-2480

Authors: Wissner, A Berger, DM Boschelli, DH Floyd, MB Greenberger, LM Gruber, BC Johnson, BD Mamuya, N Nilakantan, R Reich, MF Shen, R Tsou, HR Upeslacis, E Wang, YF Wu, BQ Ye, F Zhang, N

Citation: A. Wissner et al., 4-Anilino-6,7-dialkoxyquinolime-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors, J MED CHEM, 43(17), 2000, pp. 3244-3256

Authors: Discafani, CM Carroll, ML Floyd, MB Hollander, IJ Husain, Z Johnson, BD Kitchen, D May, MK Malo, MS Minnick, AA Nilakantan, R Shen, R Wang, YF Wissner, A Greenberger, LM

Citation: Cm. Discafani et al., Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785), BIOCH PHARM, 57(8), 1999, pp. 917-925